BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23890144)

  • 1. Imaging of indeterminate pancreatic cystic lesions: a systematic review.
    Jones MJ; Buchanan AS; Neal CP; Dennison AR; Metcalfe MS; Garcea G
    Pancreatology; 2013; 13(4):436-42. PubMed ID: 23890144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study.
    Kauhanen S; Rinta-Kiikka I; Kemppainen J; Grönroos J; Kajander S; Seppänen M; Alanen K; Gullichsen R; Nuutila P; Ovaska J
    J Nucl Med; 2015 Aug; 56(8):1163-8. PubMed ID: 26045314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.
    Sperti C; Pasquali C; Decet G; Chierichetti F; Liessi G; Pedrazzoli S
    J Gastrointest Surg; 2005 Jan; 9(1):22-8; discussion 28-9. PubMed ID: 15623441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas.
    Sperti C; Pasquali C; Chierichetti F; Liessi G; Ferlin G; Pedrazzoli S
    Ann Surg; 2001 Nov; 234(5):675-80. PubMed ID: 11685032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
    Srinivasan N; Koh YX; Goh BKP
    Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts.
    Sainani NI; Saokar A; Deshpande V; Fernández-del Castillo C; Hahn P; Sahani DV
    AJR Am J Roentgenol; 2009 Sep; 193(3):722-31. PubMed ID: 19696285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoepithelial cysts of the pancreas. Can preoperative imaging distinguish this benign lesion from malignant or pre-malignant cystic pancreatic lesions?
    Kavuturu S; Sarwani NE; Ruggeiro FM; Deshaies I; Kimchi ET; Kaifi JT; Staveley-O'Carroll KF; Gusani NJ
    JOP; 2013 May; 14(3):250-5. PubMed ID: 23669473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
    Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Radiological Imaging in the Diagnosis and Characterization of Pancreatic Cystic Lesions: A Systematic Review.
    Mohamed E; Jackson R; Halloran CM; Ghaneh P
    Pancreas; 2018 Oct; 47(9):1055-1064. PubMed ID: 30199486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron-emission tomography and computed tomography of cystic pancreatic masses.
    Tann M; Sandrasegaran K; Jennings SG; Skandarajah A; McHenry L; Schmidt CM
    Clin Radiol; 2007 Aug; 62(8):745-51. PubMed ID: 17604762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative accuracy of CT and MRI in the differentiation of benign from malignant pancreatic cystic lesions.
    Lee HJ; Kim MJ; Choi JY; Hong HS; Kim KA
    Clin Radiol; 2011 Apr; 66(4):315-21. PubMed ID: 21356393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of MRI for Differentiation of Benign and Malignant Pancreatic Cystic Lesions Compared to CT and Endoscopic Ultrasound: Systematic Review and Meta-analysis.
    Udare A; Agarwal M; Alabousi M; McInnes M; Rubino JG; Marcaccio M; van der Pol CB
    J Magn Reson Imaging; 2021 Oct; 54(4):1126-1137. PubMed ID: 33847435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of endoscopic ultrasound, computed tomography and magnetic resonance imaging in assessment of detailed structures of pancreatic cystic neoplasms.
    Du C; Chai NL; Linghu EQ; Li HK; Sun LH; Jiang L; Wang XD; Tang P; Yang J
    World J Gastroenterol; 2017 May; 23(17):3184-3192. PubMed ID: 28533675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of (18)F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with (18)F-FDG PET/CT.
    Nagamachi S; Nishii R; Wakamatsu H; Mizutani Y; Kiyohara S; Fujita S; Futami S; Sakae T; Furukoji E; Tamura S; Arita H; Chijiiwa K; Kawai K
    Ann Nucl Med; 2013 Jul; 27(6):554-63. PubMed ID: 23580090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should we do EUS/FNA on patients with pancreatic cysts? The incremental diagnostic yield of EUS over CT/MRI for prediction of cystic neoplasms.
    Khashab MA; Kim K; Lennon AM; Shin EJ; Tignor AS; Amateau SK; Singh VK; Wolfgang CL; Hruban RH; Canto MI
    Pancreas; 2013 May; 42(4):717-21. PubMed ID: 23558241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-fluorodeoxyglucose positron emission tomography in management of pancreatic cystic tumors.
    Zhang Y; Frampton AE; Martin JL; Kyriakides C; Bong JJ; Habib NA; Vlavianos P; Jiao LR
    Nucl Med Biol; 2012 Oct; 39(7):982-5. PubMed ID: 22560970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.